Jean-Philippe Drolet

Fitzpatrick T, Yamoah P, Lacuesta G, Sadarangani M, Cook V, Pourshahnazari P, Kalicinsky C, Upton JEM, Cameron SB, Zaborniak K, Kanani A, Lam G, Burton C, Constantinescu C, Pernica JM, Abdurrahman Z, Betschel S, Drolet JP, De Serres G, Quach C, Des Roches A, Chapdelaine H, Salvadori MI, Carignan A, McConnell A, Pham-Huy A, Buchan CA, Cowan J, Hildebrand K, Top KA,

Revaccination outcomes among adolescents and adults with suspected hypersensitivity reactions following COVID-19 vaccination: A Canadian immunization research network study

Vaccine, 42 (24), 2024.

Résumé | Liens:

Brillant-Marquis F, Proulx É, Ratnarajah K, Lavoie A, Gauthier A, Gagnon R, Boursiquot JN, Verreault N, Marois L, Bédard MA, Boivin M, Bédard PM, Ouakki M, De Serres G, Drolet JP

Safety of Direct Drug Provocation for the Evaluation of Penicillin Allergy in Low-Risk Adults

J Allergy Clin Immunol Pract, 12 (2), 2024.

Résumé | Liens:

Simard ML, Novak N, Drolet JP, Joly MC, Nolte H, Wuestenberg E, Gagnon R

Tolerability of sublingual versus vestibular allergy immunotherapy tablet administration: A randomized pilot study

Clin Exp Allergy, 54 (2), 2024.

Résumé | Liens:

Picard M, Drolet JP, Masse MS, Filion CA, ALMuhizi F, Fein M, Copaescu A, Isabwe GAC, Blaquière M, Primeau MN

Safety of COVID-19 vaccination in patients with polyethylene glycol allergy: A case series

J Allergy Clin Immunol Pract, 10 (2), 2022.

| Liens:

Zafack JG, Toth E, Landry M, Drolet JP, Top KA, De Serres G

Rate of Recurrence of Adverse Events Following Immunization: Results of 19 Years of Surveillance In Quebec, Canada

Pediatr Infect Dis J, 38 (4), 2019.

Résumé | Liens:

Desjardins M, Béland M, Dembele M, Lejtenyi D, Drolet JP, Lemire M, Tsoukas C, Ben-Shoshan M, Noya FJD, Alizadehfar R, McCusker CT, Mazer BD

Modulation of the Interleukin-21 Pathway with Interleukin-4 Distinguishes Common Variable Immunodeficiency Patients with More Non-infectious Clinical Complications

J Clin Immunol, 38 (1), 2018.

Résumé | Liens:

Zafack JG, De Serres G, Rouleau I, Gariepy MC, Gagnon R, Drolet JP, Skowronski DM

Clinical Approach Used in Medical Consultations for Allergic-Like Events Following Immunization: Case Series Report in Relation to Practice Guidelines

J Allergy Clin Immunol Pract, 5 (3), 2017.

Résumé | Liens:

Viel-Theriault I, Thibeault R, Boucher FD, Drolet JP

Thalidomide in Refractory Tuberculomas and Pseudoabscesses

Pediatr Infect Dis J, 35 (11), 2016.

Résumé | Liens:

Rouleau I, De Serres G, Skowronski DM, Drolet JP, Lemire C, Toth E, Landry M

Risk factors associated with anaphylaxis and other allergic-like events following receipt of 2009 monovalent AS03-adjuvanted pandemic influenza vaccine in Quebec, Canada

Vaccine, 32 (28), 2014.

Résumé | Liens:

Rouleau I, De Serres G, Drolet JP, Skowronski D, Ouakki M, Toth E, Landry M, Menard S, Gagnon R

Increased risk of anaphylaxis following administration of 2009 AS03-adjuvanted monovalent pandemic A/H1N1 (H1N1pdm09) vaccine

Vaccine, 31 (50), 2013.

Résumé | Liens: